Introduction
Vitiligo is an idiopathic leukoderma often with a progressive course causing destruction of melanocytes 1 . It may be defined as a specific, 
Material and Methods
This is an prospective longitudinal interventional study, carried out in the depigmented area was assessed according to the department of Dermatology and Venereology, Combined Military Hospital, Dhaka in between the duration of April 2010 to March 2011. Study was included 25 vitiligo patients based on inclusion criteria like patient with vitiligo affecting more than 5% body surface area, patient having ivory-white fluorescence on Wood's lamp, patient who were above 15 years of age, patient who had given written consent, patient was not taken any previous treatment etc. The exclusion criteria include patient unwilling to give informed consent, pregnant women and lactating mother, history of hypersensitivity with phototherapy and/or psoralen, patient suffering liver disease, kidney disease, thyroid disease and diabetes mellitus.
Treatment procedure: Before inclusion in the study, all the participants were elaborately informed about the natural history and prognosis of their disease, proper application procedures for the phototherapy, possible therapeutic outcomes and adverse effects. So that they can make independent decision about their participation. They were assured of strict privacy and secrecy of information on all occasions and as such necessary measures were taken beforehand. In addition to clinical examination the following investigations has done in all cases-Wood's lamp examination, liver function tests, fasting blood sugar and 2 hours after breakfast, blood urea and serum creatinine, serum calcium level, antinuclear antibody test and thyroid function tests.
Patients were given oral 8-MOP (8-Methoxypsoralen) at a dose of 0.6 mg/kg body weight two hours before the exposure of UVA. The initial UVA dosages were 1.5 J/cm 2 and gradually increased the dose. Treatments were carried out twice in a week. All patients received 48 sessions of PUVA therapy over whole body with eye protection. Efficacy was evaluated in every follow up visit at 4 weeks interval and finally evaluated at his or her 6th follow up visit. In each patient, the size of rule of nine before treatment. Photographic records were taken before and after treatment. Treatment efficacies will be classified into five groups (designated A-E):
The scoring was done on the basis of induced repigmentation in vitiligo spots and the responses in each visit were endorsed in the study protocol. By the end of the therapy, the percentage, score for each patient was evaluated by statistical analysis which.
Results
A prospective longitudinal interventional study, carried out in the department of Dermatology and Venereology, Combined Military Hospital, Dhaka cantonment, Dhaka to see the efficacy of systemic PUVA in the treatment of Vitiligo.
Fig-1: Distribution of the patients by age (n=25).
Figure-1 shows the age distribution of the patients. In study group the patient's age was between 15-45 years and mean age was 28.16 years. The highest number of the participant was between the 15-25 years aged group. Figure-3 Shows the duration of the lesions of the patients. The range of duration in study group was 02 years to 16 years. Among the 25 cases of study group maximum duration of the lesions were 4-6 Yrs 10 (40%) followed by 1-3 Yrs 09 (36%), 7-9 Yrs 04 (16%) and >9 Yrs 02 (08%). Maximum number of lesions in study group was between 11-20 followed by less than 10. 
Conclusion
Systemic PUVA for the repigmentation of vitiligo seems to be effective. Our studies have shown the efficacy of systemic PUVA in the treatment of vitiligo. Study needs large number of patients for longer period of duration for confirmation of results.
